(HEWA) & Rite Aid (RAD) Head to Head Review (OTCMKTS: HEWA) and Rite Aid (NYSE:RAD) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, profitability, risk, institutional ownership and valuation.

Earnings & Valuation

This table compares and Rite Aid’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio $14.85 million 1.75 $370,000.00 N/A N/A
Rite Aid $21.53 billion 0.08 $943.47 million ($0.02) -84.50

Rite Aid has higher revenue and earnings than

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for and Rite Aid, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 0 0 0 0 N/A
Rite Aid 2 5 1 0 1.88

Rite Aid has a consensus target price of $2.31, indicating a potential upside of 36.46%. Given Rite Aid’s higher probable upside, analysts plainly believe Rite Aid is more favorable than

Volatility and Risk has a beta of -4.21, indicating that its stock price is 521% less volatile than the S&P 500. Comparatively, Rite Aid has a beta of 1.74, indicating that its stock price is 74% more volatile than the S&P 500.


This table compares and Rite Aid’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets -0.60% N/A N/A
Rite Aid 3.60% -8.25% -0.71%

Insider and Institutional Ownership

47.6% of Rite Aid shares are held by institutional investors. 24.5% of shares are held by company insiders. Comparatively, 2.3% of Rite Aid shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.


Rite Aid beats on 7 of the 11 factors compared between the two stocks.

About, Inc. operates an online mail order pharmacy. The company markets a range of generic, brand name, and pet prescription medicines, as well as over-the-counter (OTC) medications and products. It sells its products in 50 states and the District of Columbia in the United States to focus on the out-of-pocket prescription drug market. The company sells prescription medications and OTC products to individual consumers over the Internet., Inc. is headquartered in Florence, Kentucky.

About Rite Aid

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment sells prescription drugs; and a range of other merchandise, such as over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products. This segment also operates retail clinics that provide treatment for common conditions; and a range of preventive services, including screenings, medical tests, immunizations, and basic physical exams. In addition, this segment provides healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; offers integrated mail-order and specialty and compounding pharmacy services; and provides infertility treatment, as well as drug benefits under the federal government's Medicare Part D program. As of June 20, 2017, the company operated approximately 4,500 stores in 31 states of the United States and in the District of Columbia. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.

Receive News & Ratings for Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit